C-class oligonucleotide analogs with enhanced immunostimulatory potency

Details for Australian Patent Application No. 2006201495 (hide)

Owner Coley Pharmaceutical GmbH Coley Pharmaceutical Group, Inc.

Inventors Krieg, Arthur M.; Uhlmann, Eugen; Vollmer, Joerg; Noll, Bernard O.

Agent Davies Collison Cave

Pub. Number AU-A-2006201495

Parent 2004285561

Filing date 10 April 2006

Wipo publication date 27 April 2006

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

Event Publications

27 April 2006 Application Open to Public Inspection

  Published as AU-A-2006201495

27 April 2006 Complete Application Filed

24 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006201496-Food-quality and shelf-life predicting method and system

2006201494-A batting practice system